Down-Regulation of Bcl-2 Is a Potential Marker of the Efficacy of Progestin Therapy in the Treatment of Endometrial Hyperplasia

By Amezcua C.A.   Zheng W.   Muderspach L.I.   Felix J.C.  

Gynecologic Oncology, Vol. 73, Iss. 1, 1999-04 ,pp. : 126-136

Elsevier

Access to resources Recommend Favorite

Progestin therapy for endometrial cancer: The potential of fourth-generation progestin (Review)

By Banno Kouji   Kisu Iori   Yanokura Megumi   Tsuji Kosuke   Masuda Kenta   Ueki Arisa   Kobayashi Yusuke   Yamagami Wataru   Nomura Hiroyuki   Susumu Nobuyuki   Aoki Daisuke  

International Journal of Oncology, Vol. 40, Iss. 6, 2012-06 ,pp. : 1755-1762

Spandidos Publications

Access to resources Recommend Favorite

Endometrial Carcinoma Associated with Hyperplasia

By Kaku T.   Tsukamoto N.   Hachisuga T.   Tsuruchi N.   Sakai K.   Hirakawa T.   Amada S.   Saito T.   Kamura T.   Nakano H.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 22-25

Academic Press

Access to resources Recommend Favorite

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

By Vereide A.B.   Arnes M.   Straume B.   Maltau J.M.   Orbo A.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 526-533

Elsevier

Access to resources Recommend Favorite

Concomitant Endometrial Hyperplasia in Patients with Endometrial Carcinoma

By Gucer F.   Reich O.   Tamussino K.   Bader A.A.   Pieber D.   Scholl W.   Haas J.   Petru E.  

Gynecologic Oncology, Vol. 69, Iss. 1, 1998-04 ,pp. : 64-68

Elsevier

Access to resources Recommend Favorite